Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 155, Issue 5, Pages 588-598
Publisher
Wiley
Online
2011-09-28
DOI
10.1111/j.1365-2141.2011.08888.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mammalian Sirtuins: Biological Insights and Disease Relevance
- (2010) Marcia C. Haigis et al. Annual Review of Pathology-Mechanisms of Disease
- The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo
- (2010) G. Dasmahapatra et al. BLOOD
- SIRT1 Activation by Small Molecules
- (2010) Han Dai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
- (2010) Michelle Pacholec et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SRT1720 Induces Mitochondrial Biogenesis and Rescues Mitochondrial Function after Oxidant Injury in Renal Proximal Tubule Cells
- (2010) J. A. Funk et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma
- (2009) D. Chauhan et al. BLOOD
- PCI-24781 Induces Caspase and Reactive Oxygen Species-Dependent Apoptosis Through NF- B Mechanisms and Is Synergistic with Bortezomib in Lymphoma Cells
- (2009) S. Bhalla et al. CLINICAL CANCER RESEARCH
- Pharmaceutical Strategies for Activating Sirtuins
- (2009) Anthony Sauve CURRENT PHARMACEUTICAL DESIGN
- SirT1 Is an Inhibitor of Proliferation and Tumor Formation in Colon Cancer
- (2009) Neha Kabra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Division and apoptosis of E2f-deficient retinal progenitors
- (2009) Danian Chen et al. NATURE
- Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice
- (2008) Rui-Hong Wang et al. CANCER CELL
- Interactions between Bortezomib and Romidepsin and Belinostat in Chronic Lymphocytic Leukemia Cells
- (2008) Y. Dai et al. CLINICAL CANCER RESEARCH
- The Sirtuin family: therapeutic targets to treat diseases of aging
- (2008) Jill C Milne et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- SIRT1 Exerts Anti-Inflammatory Effects and Improves Insulin Sensitivity in Adipocytes
- (2008) T. Yoshizaki et al. MOLECULAR AND CELLULAR BIOLOGY
- SIRT1 Acts as a Nutrient-sensitive Growth Suppressor and Its Loss Is Associated with Increased AMPK and Telomerase Activity
- (2008) Swami R. Narala et al. MOLECULAR BIOLOGY OF THE CELL
- The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth
- (2008) Ron Firestein et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started